Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry-Reference-Cited by-同舟云学术

Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry

Published:2019-03-04 Issue:3 Volume:14 Page:356-360
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Alt Silke¹,Bernasconi Alice¹,Sosio Margherita¹²,Brunati Cristina¹,Donadio Stefano¹²,Maffioli Sonia I.¹²^ORCID

Affiliation:

1. Naicons Srl, Viale Ortles 22/4, 20139 Milano, Italy

2. KtedoGen Srl, Viale Ortles 22/4, 20139 Milano, Italy

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.9b00050

Reference28 articles.

1. Industrial natural product chemistry for drug discovery and development

2. Durata Therapeutics Ltd. (2015) Dalvance (dalbavancin) for injection for intravenous use: US prescribing information. https://www.allergan.com/assets/pdf/dalvance_pi.

3. A40926, a new glycopeptide antibiotic with anti-Neisseria activity

4. Classification of Nonomuraea sp. ATCC 39727, an actinomycete that produces the glycopeptide antibiotic A40926, as Nonomuraea gerenzanensis sp. nov.

5. Comparative analysis and insights into the evolution of gene clusters for glycopeptide antibiotic biosynthesis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approved antibacterial drugs in the last 10 years: from the bench to the clinic;Exploration of Drug Science;2023-06-30

2. Clinically Approved Antibiotics from 2010 to 2022;CHIMIA;2023-04-26

3. Establishment of a visual gene knockout system based on CRISPR/Cas9 for the rare actinomycete Nonomuraea gerenzanensis;Biotechnology Letters;2023-01-18

4. Newest perspectives of glycopeptide antibiotics: biosynthetic cascades, novel derivatives, and new appealing antimicrobial applications;World Journal of Microbiology and Biotechnology;2023-01-03

5. Carbazole Derivatives as Potential Antimicrobial Agents;Molecules;2022-10-04